LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Search

Danaher Corp

Open

Sector Healthcare

246.73 -0.33

Overview

Share price change

24h

Current

Min

245.83

Max

251.42

Key metrics

By Trading Economics

Income

-89M

818M

Sales

100M

5.8B

P/E

Sector Avg

51.11

104.138

EPS

1.71

Profit margin

14.103

Employees

61,000

EBITDA

-73M

1.7B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+17.07 upside

Dividends

By Dow Jones

Next Earnings

28 sty 2025

Next Dividend date

24 sty 2025

Next Ex Dividend date

26 gru 2024

Market Stats

By TradingEconomics

Market Cap

-941M

184B

Previous open

247.06

Previous close

246.73

News Sentiment

By Acuity

17%

83%

32 / 390 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Danaher Corp Chart

Past performance is not a reliable indicator of future results.

Related News

22 paź 2024, 10:35 UTC

Earnings

Danaher 3Q EPS, Sales Top Views on Strong Cepheid Test Demand

23 lip 2024, 10:55 UTC

Earnings

Danaher Expects 3Q Core Sales Drop, Backs 2024 Guidance

23 kwi 2024, 10:46 UTC

Earnings

Danaher Posts Fall in 1Q Earnings, Continues to Expects Lower Annual Sales

22 paź 2024, 10:02 UTC

Earnings

Danaher 3Q Adjusted Core Revenue Rose 0.5% >DHR

22 paź 2024, 10:02 UTC

Earnings

Danaher Still Sees 2024 Adjusted Core Revenue Down Low-Single Digits >DHR

22 paź 2024, 10:01 UTC

Earnings

Danaher Sees 4Q Adjusted Core Revenue Down Low-Single Digits >DHR

22 paź 2024, 10:00 UTC

Earnings

Danaher 3Q Operating Cash Flow $1.5B, Adjusted Free Cash Flow $1.2B >DHR

22 paź 2024, 10:00 UTC

Earnings

Danaher 3Q Sales $5.8B >DHR

22 paź 2024, 10:00 UTC

Earnings

Danaher 3Q EPS $1.12 >DHR

22 paź 2024, 10:00 UTC

Earnings

Danaher 3Q Adj EPS $1.71 >DHR

22 paź 2024, 10:00 UTC

Earnings

Danaher 3Q Net $818M >DHR

22 paź 2024, 10:00 UTC

Earnings

Danaher 3Q Cont Ops EPS $1.12 >DHR

23 lip 2024, 12:39 UTC

Top News
Earnings

Danaher Stock Surges. More Than Earnings Are Driving It Higher. -- Barrons.com

23 lip 2024, 10:05 UTC

Earnings

Danaher 2Q Adjusted Core Revenue Fell 3.5% >DHR

23 lip 2024, 10:05 UTC

Earnings

Danaher Sees 2024 Adjusted Core Revenue Down Low-Single Digits >DHR

23 lip 2024, 10:04 UTC

Earnings

Danaher Sees 3Q Adjusted Core Revenue Down Low-Single Digits >DHR

23 lip 2024, 10:04 UTC

Earnings

Danaher 2Q Operating Cash Flow $1.4B, Adjusted Free Cash Flow $1.1B >DHR

23 lip 2024, 10:00 UTC

Earnings

Danaher 2Q Adj EPS $1.72 >DHR

23 lip 2024, 10:00 UTC

Earnings

Danaher 2Q Cont Ops EPS $1.22 >DHR

23 lip 2024, 10:00 UTC

Earnings

Danaher 2Q EPS $1.22 >DHR

23 lip 2024, 10:00 UTC

Earnings

Danaher 2Q Net $907M >DHR

23 lip 2024, 10:00 UTC

Earnings

Danaher 2Q Sales $5.7B >DHR

23 kwi 2024, 15:33 UTC

Earnings

Earnings Today: PulteGroup, Danaher Rally; JetBlue Dives -- IBD

23 kwi 2024, 14:56 UTC

Hot Stocks

Stocks to Watch Tuesday: GM, Spotify, UPS, Tesla -- WSJ

23 kwi 2024, 12:13 UTC

Earnings

Danaher Stock Jumps After Earnings Beat. It Shrugs Off Falling Sales Outlook. -- Barrons.com

23 kwi 2024, 10:01 UTC

Earnings

Danaher Continues to Expect FY Core Rev Will Be Dn Low-Single Digits Yr-over-Yr >DHR

23 kwi 2024, 10:01 UTC

Earnings

Danaher Sees 2Q Core Rev Dn Mid-Single Digits Yr-over-Yr >DHR

23 kwi 2024, 10:00 UTC

Earnings

Danaher 1Q Net $1.09B >DHR

23 kwi 2024, 10:00 UTC

Earnings

Danaher 1Q Sales $5.8B >DHR

23 kwi 2024, 10:00 UTC

Earnings

Danaher 1Q Cont Ops EPS $1.45 >DHR

Peer Comparison

Price change

Danaher Corp Forecast

Price Target

By TipRanks

17.07% upside

12 Months Forecast

Average 290.06 USD  17.07%

High 315 USD

Low 255 USD

Based on 16 Wall Street analysts offering 12 month price targets forDanaher Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

16 ratings

11

Buy

5

Hold

0

Sell

Technical Score

By Trading Central

244.89 / 247.82Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Very Strong Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

32 / 390 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Danaher Corp

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through three segments: Life Sciences, which offers a range of instruments and consumables that are used by customers to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines; Diagnostics, which offers analytical instruments, reagents, consumables, software and services, and Environmental & Applied Solutions, which offers products and services that help protect important resources and keep global food and water supplies safe. Its business research and development, manufacturing, sales, distribution, service and administrative facilities are located in over 60 countries.